Carl June, MD, Talks CAR T-cell Therapies at AACR Conference
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
Category: AACR
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
Radiotherapy is a mainstay of cancer treatment. In recent years, improved technology has allowed many cancer patients to receive...
Pancreatic cancer remains a challenging disease to treat, with a five-year survival rate of less than 9 percent, according...
Wen-Yang Lin, PhD, MS, currently a postdoctoral fellow at Stanford University and the recipient of the 2017 AACR-Genentech Fellowship...
Every month, the editors from the eight scientific journals published by the American Association for Cancer Research (AACR) select...
The human microbiome – the collection of bacteria, viruses, fungi, and other microorganisms that live inside and on the...
Much of the excitement revolving around cancer immunotherapy is focused on checkpoint inhibitors – drugs that “release the brakes”...
Cancer patient advocates take on many roles in their communities. They may go out to churches to promote the...
Dong-Joo (Ellen) Cheon, PhD, Assistant Professor of Regenerative and Cancer Cell Biology at Albany Medical College and the 2017...
Thanks to decades of cancer research that have brought us groundbreaking discoveries and treatments, 15.5 million U.S. cancer survivors...